×

CochLear Total Liabilities and Share Holders Equity 2023-2024 | CHEOY

CochLear total liabilities and share holders equity from 2023 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • CochLear total liabilities and share holders equity for the quarter ending June 30, 2024 was $1.800B, a INF% increase year-over-year.
  • CochLear total liabilities and share holders equity for 2024 was $1.8B, a 4.11% increase from 2023.
  • CochLear total liabilities and share holders equity for 2023 was $1.729B, a 3.31% decline from 2022.
  • CochLear total liabilities and share holders equity for 2022 was $1.788B, a INF% increase from 2021.
CochLear Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2024 $1,800
2023 $1,729
2022 $1,788
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
CochLear Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $1,800
2023-06-30 $1,729
2022-06-30 $1,788
Sector Industry Market Cap Revenue
Medical Medical Services $13.090B $1.488B
Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $90.619B 11.24
Cencora (COR) United States $47.732B 17.95
DiDi Global (DIDIY) China $22.844B 0.00
Natera (NTRA) United States $22.698B 0.00
ICON (ICLR) Ireland $16.752B 14.92
Avantor (AVTR) United States $15.042B 22.55
Revvity (RVTY) United States $14.943B 25.96
BioMerieux (BMXMF) France $13.831B 0.00
Viatris (VTRS) United States $13.297B 4.10
Solventum (SOLV) United States $12.725B 0.00
Medpace Holdings (MEDP) United States $10.729B 30.23
Doximity (DOCS) United States $10.460B 61.57
EUROFINS SCIENT (ERFSF) Luxembourg $9.632B 0.00
HealthEquity (HQY) United States $9.166B 45.99
Charles River Laboratories (CRL) United States $8.602B 16.62
Sonic Healthcare (SKHHY) Australia $8.397B 0.00
Amplifon S.p.A (AMFPF) Italy $6.136B 31.28
Bausch + Lomb (BLCO) Canada $6.016B 27.98
Organon (OGN) United States $4.087B 4.12
Sotera Health (SHC) United States $3.852B 20.61
BrightSpring Health Services (BTSG) United States $3.690B 78.48
Concentras Parent (CON) United States $2.819B 0.00
Alignment Healthcare (ALHC) United States $2.801B 0.00
Surgery Partners (SGRY) United States $2.587B 29.49
PACS (PACS) United States $2.147B 0.00
Premier (PINC) United States $2.116B 11.01
GeneDx Holdings (WGS) United States $2.082B 0.00
Ardent Health Partners (ARDT) United States $2.075B 0.00
Progyny (PGNY) United States $1.801B 36.47
GoodRx Holdings (GDRX) United States $1.795B 47.10
Teladoc Health (TDOC) United States $1.701B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.658B 0.00
Agilon Health (AGL) United States $1.463B 0.00
CareDx (CDNA) United States $1.244B 0.00
Pediatrix Medical (MD) United States $1.208B 11.82
Embecta (EMBC) United States $1.089B 7.62
AMN Healthcare Services Inc (AMN) United States $1.022B 6.91
Establishment Labs Holdings (ESTA) $1.014B 0.00
Auna S.A (AUNA) Luxembourg $0.609B 0.00
SBC Medicals (SBC) United States $0.521B 0.00
InnovAge Holding (INNV) United States $0.501B 0.00
DocGo (DCGO) United States $0.448B 16.89
Sonida Senior Living (SNDA) United States $0.441B 0.00
QDM (QDMI) Hong Kong, SAR China $0.426B 11.15
Enhabit (EHAB) United States $0.398B 34.39
MultiPlan (MPLN) United States $0.259B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.255B 0.00
Sera Prognostics (SERA) United States $0.220B 0.00
LifeMD (LFMD) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.207B 0.00
Nutex Health (NUTX) United States $0.207B 0.00
Performant Healthcare (PHLT) United States $0.189B 0.00
Biodesix (BDSX) United States $0.145B 0.00
So-Young (SY) China $0.105B 17.80
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
ModivCare (MODV) United States $0.077B 4.20
IceCure Medical (ICCM) Israel $0.065B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
Oncology Institute (TOI) United States $0.053B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.033B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.032B 0.00
Co-Diagnostics (CODX) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.024B 0.00
KindlyMD (KDLY) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00